Please note: The information displayed on this page might be outdated.
Saniona: A research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. The company has a significant portfolio of potential drug candidates at pre-clinical and clinical stage. The research is focused on ion channels, which makes up a unique protein class that enables and controls the passage of charged ions across cell membranes. Saniona has ongoing collaboration agreements with Boehringer Ingelheim GmbH, Upsher-Smith Laboratories, Inc., Productos Medix, S.A and Luc Therapeutics, Inc.
Based in...
Europe, Public
Market Cap
100MM - 500MM
Ballerup, Hovedstaden

Company Participants at Danish Science and The City DKBIO 17

  • Jørgen Drejer

Top 10 Holders of Saniona AB

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
RA Capital Management LP 18.61 11,608,906 0.00 Stakes 12/31/20
Fjärde AP-fonden 3.03 1,886,792 0.00 Stakes 12/31/20
Tredje AP-fonden 3.02 1,880,570 0.00 Funds 12/31/20
Nordea Investment Management AB 1.25 778,259 0.00 Stakes 9/30/20
Handelsbanken Fonder AB 0.56 346,555 0.00 Funds 8/31/21
SEB Investment Management AB 0.53 330,462 0.00 Funds 8/31/21
Abante Asesores Gestión SGIIC SA 0.22 135,088 0.00 Funds 12/31/20
Skandia Investment Management AB 0.07 45,316 0.00 Funds 7/30/21
Storebrand Asset Management AS 0.04 25,238 0.00 Funds 8/31/21
Catella Fondförvaltning AB 0.03 15,818 0.00 Funds 8/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.